Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2000
Buy Report

Published: March 31, 2022 Report Code: GMDGDHC22050IDB-ST

Select Item

Cholera pipeline market research report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cholera and features dormant and discontinued projects.

Key Targets in the Cholera Pipeline Market

The key targets in the cholera pipeline market report are Cystic Fibrosis Transmembrane Conductance Regulator, Alpha 1 Adrenergic Receptor, Beta 1 Adrenergic Receptor, Cell Membrane, Synaptic Vesicular Amine Transporter, and Vibrio cholerae RbmA Protein. Cystic Fibrosis Transmembrane Conductance Regulator has the highest number of pipeline products.

Cholera Pipeline Market, by Targets

Cholera Pipeline Market, by Targets

For more target insights, download a free report sample

Key MoA in the Cholera Pipeline Market

The key MoA in the cholera pipeline market are Cystic Fibrosis Transmembrane Conductance Regulator Blocker, Alpha 1 Adrenergic Receptor Antagonist, Beta 1 Adrenergic Receptor Antagonist, Cell Membrane Disruptor, and Synaptic Vesicular Amine Transporter Inhibitor. Cystic Fibrosis Transmembrane Conductance Regulator Blocker has the highest number of pipeline products.

Cholera Pipeline Market, by MoA

Cholera Pipeline Market, by MoA

For more MoA insights, download a free report sample

Key RoA in the Cholera Pipeline Market

The key RoA in the cholera pipeline market is oral.

Key Molecule Types in the Cholera Pipeline Market

The key molecule types in the cholera pipeline market are small molecule, inactivated vaccine, live attenuated vaccine, subunit vaccine, antibody, peptide, and synthetic peptide. Small molecule has the highest number of pipeline products.

Cholera Pipeline Market, by Molecule Type

Cholera Pipeline Market, by Molecule Type

For more molecule type insights, download a free report sample

Key Companies in the Cholera Pipeline Market

The key companies in the cholera pipeline market are Bharat Biotech Ltd, Emergent BioSolutions Inc, Global BioLife Inc Ltd, Napo Pharmaceuticals Inc, Ostrich Pharma USA Inc, SOM Biotech SL, and Vanda Pharmaceuticals Inc.

Market report overview

Key targets Cystic Fibrosis Transmembrane Conductance Regulator, Alpha 1 Adrenergic Receptor, Beta 1 Adrenergic Receptor, Cell Membrane, Synaptic Vesicular Amine Transporter, and Vibrio cholerae RbmA Protein
Key MoA Cystic Fibrosis Transmembrane Conductance Regulator Blocker, Alpha 1 Adrenergic Receptor Antagonist, Beta 1 Adrenergic Receptor Antagonist, Cell Membrane Disruptor, and Synaptic Vesicular Amine Transporter Inhibitor
Key RoA Oral
Key molecule types Small Molecule, Inactivated Vaccine, Live Attenuated Vaccine, Subunit Vaccine, Antibody, Peptide, and Synthetic Peptide
Key companies Bharat Biotech Ltd, Emergent BioSolutions Inc, Global BioLife Inc Ltd, Napo Pharmaceuticals Inc, Ostrich Pharma USA Inc, SOM Biotech SL, and Vanda Pharmaceuticals Inc

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Cholera (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Cholera (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Cholera (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Cholera (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Cholera (Infectious Disease)

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

  • Find and recognize significant and varied types of therapeutics under development for Cholera (Infectious Disease).

  • Classify potential new clients or partners in the target demographic.

  • Develop tactical initiatives by understanding the focus areas of leading companies.

  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

  • Formulate corrective measures for pipeline projects by understanding Cholera (Infectious Disease) pipeline depth and focus of Indication therapeutics.

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Bharat Biotech Ltd
Emergent BioSolutions Inc
Global BioLife Inc Ltd
Napo Pharmaceuticals Inc
Ostrich Pharma USA Inc
SOM Biotech SL
Vanda Pharmaceuticals Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Cholera – Overview

Cholera – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Cholera – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Cholera – Companies Involved in Therapeutics Development

Bharat Biotech Ltd

Emergent BioSolutions Inc

Global BioLife Inc Ltd

Napo Pharmaceuticals Inc

Ostrich Pharma USA Inc

SOM Biotech SL

Vanda Pharmaceuticals Inc

Cholera – Drug Profiles

Antibodies for Cholera – Drug Profile

Product Description

Mechanism Of Action

bevantolol – Drug Profile

Product Description

Mechanism Of Action

BPO-27 – Drug Profile

Product Description

Mechanism Of Action

History of Events

cholera (whole cell) vaccine – Drug Profile

Product Description

Mechanism Of Action

cholera [serotypes O1 + O139] (bivalent) vaccine – Drug Profile

Product Description

Mechanism Of Action

History of Events

cholera [strain O1/El/Tor/Ogawa] vaccine – Drug Profile

Product Description

Mechanism Of Action

cholera [strains O1 Inaba + O1 Ogawa] (whole cell) vaccine – Drug Profile

Product Description

Mechanism Of Action

History of Events

cholera strain [CVD 103-HgR] vaccine – Drug Profile

Product Description

Mechanism Of Action

History of Events

cholera vaccine – Drug Profile

Product Description

Mechanism Of Action

cholera vaccine – Drug Profile

Product Description

Mechanism Of Action

Cholvax – Drug Profile

Product Description

Mechanism Of Action

History of Events

crofelemer DR – Drug Profile

Product Description

Mechanism Of Action

History of Events

IMSUTMR-1501 – Drug Profile

Product Description

Mechanism Of Action

History of Events

LB-2 – Drug Profile

Product Description

Mechanism Of Action

Peptide for Cholera and Guillain-Barre Syndrome – Drug Profile

Product Description

Mechanism Of Action

Small Molecules for Bacterial Infections – Drug Profile

Product Description

Mechanism Of Action

Synthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections – Drug Profile

Product Description

Mechanism Of Action

Cholera – Dormant Projects

Cholera – Discontinued Products

Cholera – Product Development Milestones

Featured News & Press Releases

Jan 28, 2021: CHMP recommended extensions of indication for Vaxchora

Jan 31, 2020: Emergent BioSolutions receives positive CHMP opinion for Vaxchora; anticipates near-term approval by European Medicines Agency

Oct 28, 2019: IVI awarded $4.5 million grant to increase accessibility of oral cholera vaccine

Jun 04, 2019: Emergent BioSolutions announces FDA approval of change in storage conditions and transfer of manufacturing for its cholera vaccine

Jun 13, 2018: Fast-acting Cholera Vaccine Could Curb Outbreaks

Dec 11, 2017: PaxVax: Single-dose vaccine could provide faster protection in cholera epidemics

Dec 06, 2017: Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics

Oct 12, 2017: Hilleman Labs achieves successful outcome of Phase I/II Clinical Trial of its Oral Cholera Vaccine Hillchol

Oct 01, 2017: Hilleman Laboratories awarded global patents for Oral Cholera Vaccine

Sep 28, 2017: Hilleman Laboratories receives Indo-Swedish grant for developing – Oral Cholera Vaccine (OCV)

Oct 24, 2016: PaxVax’s Vaxchora Now Available as the Only U.S. Approved Vaccine for Protection Against Cholera

Jun 23, 2016: CDC Advisory Committee On Immunization Practices Votes To Recommend Vaxchora, PaxVax’s Single-Dose Oral Cholera Vaccine

Jun 20, 2016: FDA Approves PaxVax to Manufacture Vaxchora (Oral Cholera Vaccine) at SynCo Bio Partners

Jun 10, 2016: FDA approves vaccine to prevent cholera for travelers

Apr 27, 2016: Hilleman Laboratories advances two vaccines into clinical stage

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Cholera, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Universities/Institutes, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Cholera – Pipeline by Bharat Biotech Ltd, 2022

Cholera – Pipeline by Emergent BioSolutions Inc, 2022

Cholera – Pipeline by Global BioLife Inc Ltd, 2022

Cholera – Pipeline by Napo Pharmaceuticals Inc, 2022

Cholera – Pipeline by Ostrich Pharma USA Inc, 2022

Cholera – Pipeline by SOM Biotech SL, 2022

Cholera – Pipeline by Vanda Pharmaceuticals Inc, 2022

Cholera – Dormant Projects, 2022

Cholera – Discontinued Products, 2022

Figures

List of Figures

Number of Products under Development for Cholera, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Targets, 2022

Number of Products by Stage and Targets, 2022

Number of Products by Mechanism of Actions, 2022

Number of Products by Stage and Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

Frequently asked questions

Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update standard reports
Currency USD
$2,000

Can be used by individual purchaser only

Most Popular
$4,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$6,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Infectious Disease reports
Pharmaceuticals
New
Cell and Gene Therapies in Ophthalmology - Disease Overview, Treatment…
$6,995 | March 2024
Pharmaceuticals
New
Clinical Trials Scorecard for Investigations in 2023
$695 | March 2024
Pharmaceuticals
New
Borderline Personality Disorder (BPD) Clinical Trial Analysis by Phase, Trial…
$2,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more